Q4 miss hits Hudbay Minerals (HBM.TO, TSX) on 20 Feb 2026: earnings impact ahead

HBM.TO stock opened lower after Hudbay Minerals reported fourth-quarter results on 20 Feb 2026. Shares trade at C$32.53, down -4.86% intraday on the TSX as investors digest mixed beats and misses. The quarter showed higher revenue but softer adjusted EPS versus elevated street expectations. Our earnings spotlight connects the numbers to valuation, analyst views, and near-term trading triggers for Hudbay Minerals Inc. on the TSX in Canada.

Q4 earnings snapshot and market reaction

Hudbay reported Q4 revenue of C$732.90 million and adjusted EPS of C$0.22. The EPS missed the pre-release consensus of C$0.40, which triggered the intraday decline. Trading volume is 1,255,736.00 shares versus an average of 1,628,072.00, showing above-average selling pressure. Management will host the earnings call shortly and guidance commentary will shape the next trading session.

Drivers behind the quarter and operational notes

Volume gains in Peru and higher metal prices lifted revenue year over year. Cost controls and gold byproduct credits improved margins. Production disruptions in Manitoba and British Columbia limited upside. Management highlighted a sequential recovery after earlier wildfires and port deferrals. These operational swings explain revenue growth but also the EPS miss.

Valuation and key financial metrics for HBM.TO stock

Hudbay trades at PE 21.43 on reported EPS 1.58 and market cap C$13,413,592,917.00. Price relative to book is PB 3.23 and price-to-sales is 4.81. Free cash flow yield stands near 3.18% and debt-to-equity is 0.36. Those ratios show a mature miner with moderate leverage and limited yield for income investors.

Meyka grade, analyst context and price targets

Meyka AI rates HBM.TO with a score out of 100: 73.53 (Grade B+), suggestion BUY. This grade factors in S&P 500 and sector comparisons, financial growth, key metrics, and analyst consensus. Recent analyst notes include Citigroup’s C$32.50 price objective and a MarketBeat consensus near C$26.00. Institutional ownership sits above 57.82%, which supports liquidity and analyst coverage.

Meyka AI’s forecast model projects near-term and multi-year targets

Meyka AI’s forecast model projects a quarterly target of C$37.50 and a one-year target of C$33.03. Versus the current C$32.53, the one-year forecast implies +1.54% upside and the quarterly target implies +15.26%. The three-year projection is C$52.66, implying +61.99% upside. Forecasts are model-based projections and not guarantees.

Technicals, trading cues and sector context

Technicals show RSI 53.22 and ADX 38.69, signaling a firm trend. Day range is C$31.80 to C$33.82 and 50‑day average is C$30.23. Relative to the Basic Materials sector, Hudbay has outperformed over 12 months while the sector shows strong commodity-led gains. Watch support near C$31.00 and initial resistance around C$34.50 for intraday setups.

Final Thoughts

Key takeaways for HBM.TO stock: the Q4 report delivered stronger revenue but weaker adjusted EPS versus the recent consensus, and the stock is reacting with a -4.86% intraday move to C$32.53 on the TSX. Valuation metrics show a PE of 21.43 and a PB near 3.23, reflecting market reward for growth and commodity exposure. Meyka AI’s forecast model projects a one‑year target of C$33.03 and a three‑year target of C$52.66, implying modest near-term upside of +1.54% and larger multi-year upside of +61.99% versus today. Our Meyka grade (B+, 73.53 out of 100) balances operational improvements and geopolitical risks, and points to a BUY stance on a 12‑to‑36 month horizon. Investors should watch management guidance, Peru social risks, and copper and gold price moves for the next directional cues. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.